We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter and Ortho Clinical Partner to Deliver Infectious Disease Testing Menu

By LabMedica International staff writers
Posted on 04 Jul 2016
Beckman Coulter, Inc., (Brea, California, USA) and Ortho Clinical Diagnostics (Raritan, New Jersey, USA) have entered a strategic relationship for marketing Ortho's VITROS 3600 Immunodiagnostic System and infectious disease menu in the United States.

Ortho's VITROS 3600 System combines three high-quality proprietary technologies into a single self-monitoring system and offers a broad menu of infectious disease tests that are used by a number of leading reference laboratories in the United States. Beckman Coulter will place the VITROS 3600 System running HIV and hepatitis assays in labs that currently run its Power Processor Sample Handling Systems, and other very high-volume laboratories. This will allow very high-volume laboratories to access state-of-the-art infectious disease testing on the VITROS 3600 System and help them improve operational efficiency as well as patient care.

Beckman Coulter and Ortho will also collaborate to obtain clearance/approval from the U.S. Food and Drug Administration to connect the VITROS 3600 System to the Power Processor to run infectious disease tests.

"We look forward to working with the impressive team at Ortho to bring Ortho's high-quality infectious disease testing to our customers," said John Nosenzo, senior vice president, Customer Operations, Developed Markets at Beckman Coulter. "This relationship provides both immediate opportunity and long-term value as we continue to enhance efficiency, advance patient care and broaden our customer offerings. Through this relationship, we will be able to apply innovative technologies to deliver enhanced solutions to the highest-volume labs in the U.S."

"Ortho has long been a pioneer in infectious disease testing. Our relationship with Beckman will help us deliver that expertise to their large installed base of automated labs," said Alex Socarrás, executive vice president, Global Commercial Operations at Ortho. "We are committed to forming key strategic collaborations such as this one, which enable us to stay focused on our core business while being nimble enough to meet the varied and changing needs of our valued customers."

Related Links:
Beckman Coulter
Ortho Clinical Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Latest Industry News

Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe

ECCMID Congress Name Changes to ESCMID Global

Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform